{
    "2021-11-05": [
        [
            {
                "time": "2023-11-02",
                "original_text": "长春高新业绩会：生长激素集采价格尚未确定，地产业务占用资金不会超过100亿 资金问题",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "集采价格",
                        "地产业务",
                        "资金"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-02",
                "original_text": "长春高新：在生长激素领域，金赛药业拥有“纯化的PEG化人生长激素缀合物及其药物制剂”的发明专利和“含PEG化人生长激素缀合物的药物及其应用”等发明专利",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "金赛药业",
                        "发明专利",
                        "技术优势"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-02",
                "original_text": "长春高新：从容投资、德邦证券等31家机构于11月2日调研我司",
                "features": {
                    "keywords": [
                        "长春高新",
                        "机构调研",
                        "从容投资",
                        "德邦证券"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}